动脉粥样硬化疾病活动度与多种细胞类型糖酵解酶表达相关,并可通过FDG-PET追踪
研究在小型猪高脂饮食12个月诱导的动脉粥样硬化模型中,通过低脂饮食±MTP抑制剂BMS-212122降低血浆胆固醇3个月以降低疾病活动度。斑块消退表现为脂质含量减少、坏死核心缩小、炎症部分消退及18FDG-PET信号下降;单细胞基因表达显示平滑肌细胞、巨噬细胞和淋巴细胞糖酵解酶基因显著下调。
要点
- 小型猪高脂饮食12个月诱导动脉粥样硬化后,降胆固醇3个月可致晚期斑块消退。
- 斑块消退伴随18FDG-PET信号下降,提示其可追踪疾病活动度。
- 单细胞分析显示斑块消退涉及平滑肌细胞、巨噬细胞和淋巴细胞糖酵解酶基因下调。
核心结论
- 大型动物模型结果提示,18FDG-PET可监测动脉粥样硬化,因为疾病活动度与所有主要斑块细胞类型的糖酵解酶表达密切相关。
研究设计与样本
- 研究采用肝脏过表达功能获得性突变型前蛋白转化酶枯草溶菌素/kexin 9型(PCSK9)的小型猪斑块消退模型。
- 通过12个月高脂喂养诱导动脉粥样硬化,随后3个月以低脂饮食单用或联合微粒体转移蛋白(MTP)抑制剂BMS-212122降低血浆胆固醇以降低疾病活动度。
主要发现
- 腹主动脉晚期病变斑块消退表现为脂质含量减少、坏死核心缩小和斑块炎症部分消退,并伴随18FDG-PET信号下降。
- 单细胞基因表达谱显示,斑块消退涉及平滑肌细胞(SMC)、巨噬细胞和淋巴细胞中编码糖酵解酶的基因大幅下调,斑块细胞蛋白质组分析予以佐证。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Positron emission tomography (PET) imaging with the radiolabeled glucose analog fluorodeoxyglucose (18FDG) is used to monitor atherosclerosis in clinical trials, but there is uncertainty regarding the plaque cell types that accumulate FDG and how uptake is regulated. The long-standing view that 18FDG is mainly taken up by macrophages is at odds with human and experimental data, and the impact of disease activity on 18FDG uptake has not been examined directly. To analyze the ability of 18FDG-PET to monitor disease activity, we developed a model of plaque regression in minipigs with hepatic overexpression of a gain-of-function mutant of proprotein convertase subtilisin/kexin type 9 (PCSK9). Atherosclerosis was induced through 12 months of high-fat feeding in the porcine model. Disease activity was then lowered for 3 months by reducing plasma cholesterol with a low-fat diet alone or in combination with the microsomal transfer protein (MTP) inhibitor BMS-212122. Plaque regression in advanced lesions of the abdominal aorta was evident from reduced lipid content, reduced necrotic core size, and partial resolution of plaque inflammation and was accompanied by a decline in 18FDG-PET signal. Single-cell gene expression profiling revealed that plaque regression involved substantial down-regulation of genes encoding glycolytic enzymes in smooth muscle cells (SMCs), macrophages, and lymphocytes, which was corroborated by analysis of the plaque cellular proteome. These findings in a large-animal model suggest that 18FDG-PET can monitor atherosclerosis because of a close association between disease activity and glycolytic enzyme expression in all of the major plaque cell types.
引用
- Nogales P, Velasco C, González-Cintado L, et al. Atherosclerotic disease activity is associated with glycolytic enzyme expression across multiple cell types and is trackable by FDG-PET. Sci Transl Med. 2025. PMID: 40802740. doi:10.1126/scitranslmed.ado6467
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。